Islam Younis
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Merck & Co., Inc., Rahway, NJ, USA (United States) (2026)
Research Areas
Biography and Research Information
OverviewAI-generated summary
Islam Younis's research has focused on advancements in optical communication systems, investigating high-capacity data transmission over deployed fiber optic networks. Publications include work on achieving 1.3-Tb/s single-channel and 50.8-Tb/s WDM transmission, with field trials demonstrating these capacities. Further research explored 49.2-Tbit/s WDM transmission over 2x93-km fiber links.
More recently, Younis has contributed to clinical research, with publications in 2026 focusing on the pharmacological evaluation of novel drug candidates. This includes work on the clinical pharmacology of enlicitide decanoate, a PCSK9 inhibitor, and phase 1 studies assessing drug-drug interactions. Additional research areas include the evolution of systemic mastocytosis.
Metrics
- h-index: 3
- Publications: 6
- Citations: 65
Selected Publications
-
A 25-year evolution of systemic mastocytosis to mast cell leukemia: Cutaneous clues (2026)
Collaboration Network
Top Collaborators
- A 25-year evolution of systemic mastocytosis to mast cell leukemia: Cutaneous clues
- A 25-year evolution of systemic mastocytosis to mast cell leukemia: Cutaneous clues
- A 25-year evolution of systemic mastocytosis to mast cell leukemia: Cutaneous clues
- A 25-year evolution of systemic mastocytosis to mast cell leukemia: Cutaneous clues
Similar Researchers
Based on overlapping research topics